FDA Approval of OnPoint Vision’s Investigational Device Exemption (IDE) Application to Begin Phase I
PRESS RELEASE ALISO VIEJO, Calif., October 26, 2023, OnPoint Vision Inc, a privately held ophthalmic medical device company, announced the FDA approval of their Investigational Device Exemption (IDE) application to begin Phase I of their pivotal clinical trial of the AccuraSee™ Intraocular Pseudophakic Capsular Lens (IOPCL) Magnifier (MAG) for secondary implantation in the capsular bag … Read more